AN INSIGHT INTO THE DRUG RESISTANCE PROFILE AND MECHANISM OF DRUG RESISTANCE IN NEISSERIA GONORRHOEAE

  • 0 Review(s)

Product Category: Projects

Product Code: 00000498

No of Pages: 28

No of Chapters: 4

File Format: Microsoft Word

Price :

$12

TABLE OF CONTENTS

Title Page                                                                 i

Certification                                                     ii

Acknowledgement                                            iii

Abstract                                                           IV

CHAPTER ONE

Introduction

CHAPTER TWO

Characteristic of Neisseria Gonorrhea

CHAPTER THREE

Epidemiology

Mechanism of Drug Resistance

CHAPTER FOUR

Conclusion

Recommendation

Reference  




ABSTRACT

        Among the aetiological agents of treatable sexually transmitted diseases (STDs), Neisseria Gonorrhea is considered to be most important, because of emerging antibiotic resistance strains that compromise the effectiveness of treatment of the disease. Gonococci infections are usually treated with single – dose therapy with an agent found to cure above 95 percent of each case, but unfortunately Neisseria gonorrhea has developed resistance to most of the antibiotic used against it, which can be categorized into pre-quinolone, quinolone and post – quinolone era.

        Among the anti-biotic available so far, the third generation “cephalosporin has also be safely recommended as first line therapy for gonorrhea globally;






CHAPTER ONE

INTRODUCTION

        Despite the recent advances in diagnosis, surveillance and treatment, sexual transmitted disease (STDs) remain one of the leading diseases throughout the world. Increased promiscuity and onset of sexual activity at an early age are two important contributing factors to the spread of sexual transmitted disease.  Neisseria gonorrheae (also known as the gonococcus) colonizes primarily in the human genital urinary tract, giving rise to the sexually transmitted infection gonorrhea.  It cause both symptomatic and asymptomatic genital and extra genital tract infections.  Disease caused by this organism is a significant public health problem despite continual advances in treatment (Tanaka and Reyn et al, 2004).

World wide, there is an estimated 62million new cases a year, with an average of 22miilion cases at any given time (WHO, 1992).  N. gonorrhea inhabits mainly mucosal surface of the urethra in males and the cervix in females.  As the signs and symptoms of infection are often absent or obscure complication such as pelvic inflammatory disease (PID), infertility, entopic pregnant woman may lead to crucial perforation and blindness in the newborn. Gonococci infection have also been documented to facilitate acquisition and transmission of HIV and HPV infection (Hunter et al. 1990).  Asymptomatic infections by N. gonorrhoeae largely contribute to the persistence and transmission of disease in a community. (Hunter et, al.1990).

Therefore, to eliminate N. gonorrhea infection and in turn to control HIV and HPV infection it is important not only to screen high – risk population but also to treat them immediately with most effective drugs.  Control of gonococci infection has relied on effective single – dose antibiotic therapy given at the initial clinical visit, prior to any knowledge of the organism’s susceptibility pattern.  In the recent past, there has been an alarming increase in the number of isolate of N. gonorrhea resistance to commonly used drugs.  (Chaudhry et al, 2002).  Surveillance is therefore, necessary to understand on going resistance trends and to ensure the success of any therapy.

The irrational and injudicious use of antibacterial agents especially in the developing countries is encouraging this trend and the situation is expected to worsen unless appropriate steps are initiated. This resistance of the gonococcus to antibiotics has been the cause of much concern in recent years and has been the subject of extensive investigation.  The present review summarizes and trends to drug resistance in N. gonorrhoeae, mechanism of drug resistance and discusses the treatment regime.  In addition, the need to look for new and alternative antibacterial agent is also emphasized.



Click “DOWNLOAD NOW” below to get the complete Projects

FOR QUICK HELP CHAT WITH US NOW!

+(234) 0814 780 1594

Buyers has the right to create dispute within seven (7) days of purchase for 100% refund request when you experience issue with the file received. 

Dispute can only be created when you receive a corrupt file, a wrong file or irregularities in the table of contents and content of the file you received. 

ProjectShelve.com shall either provide the appropriate file within 48hrs or send refund excluding your bank transaction charges. Term and Conditions are applied.

Buyers are expected to confirm that the material you are paying for is available on our website ProjectShelve.com and you have selected the right material, you have also gone through the preliminary pages and it interests you before payment. DO NOT MAKE BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.

In case of payment for a material not available on ProjectShelve.com, the management of ProjectShelve.com has the right to keep your money until you send a topic that is available on our website within 48 hours.

You cannot change topic after receiving material of the topic you ordered and paid for.

Ratings & Reviews

0.0

No Review Found.


To Review


To Comment